Termination Decision: Post-DI Settlement | Sep 4, 2024 | PAPER | BOARD |
Joint Motion to Terminate | Aug 30, 2024 | PAPER | PATENT OWNER |
EX2109 | Aug 30, 2024 | EXHIBIT | PATENT OWNER |
Joint Motion to Treat Settlement Agreement as Confidential | Aug 30, 2024 | PAPER | PATENT OWNER |
ORDER Setting Oral Argument | Aug 26, 2024 | PAPER | BOARD |
Patent Owner's Request for Oral Argument | Aug 7, 2024 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Hearing | Aug 7, 2024 | PAPER | PETITIONER |
Patent Owner's Updated Exhibit List | Jul 26, 2024 | PAPER | PATENT OWNER |
Patent Owner's Sur-Reply | Jul 26, 2024 | PAPER | PATENT OWNER |
2108 - 2024.07.16 Jeffrey Ravetch Deposition Transcript (FULL) | Jul 26, 2024 | EXHIBIT | PATENT OWNER |
Notice of Deposition of J. Ravetch, M.D., Ph.D. | Jul 11, 2024 | PAPER | PATENT OWNER |
SECOND MODIFIED SCHEDULING ORDER 37 C.F.R. ยง 42.5(c) | Jul 9, 2024 | PAPER | BOARD |
Exhibit 3005 | Jul 9, 2024 | EXHIBIT | BOARD |
Stipulation Modifying Due Dates | Jul 8, 2024 | PAPER | PATENT OWNER |
Petitioner's Reply ISO Petition | Jun 10, 2024 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Jun 10, 2024 | PAPER | PETITIONER |
Deposition of Arturo Casadevall, January 24, 2020 | Jun 10, 2024 | EXHIBIT | PETITIONER |
Reply Declaration of Jeffrey V. Ravetch, M.D., Ph.D. | Jun 10, 2024 | EXHIBIT | PETITIONER |
Joint Stipulation Modifying Due Dates | May 14, 2024 | PAPER | PETITIONER |
Patent Owner Response | Mar 12, 2024 | PAPER | PATENT OWNER |
2006 - Dmytrijuk | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2014 - Greenspan | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2023 - Arturo Casadevall MD PhD CV | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2025 - CV Bernhardt Trout 504 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2028 - Hill 2007 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2029 - 1997 FDA Pts to Consider MAbs | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2030 - Alexion Press Release 3-16-2007 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2031 - Janeway Appx 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2033 - Kim 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2034 - Hwang 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2035 - Shepherd Appx 2000 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2036 - Lo 2004 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2037 - Welt 2003 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2038 - Haller 2008 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2039 - Torres 2007 PLOS Article | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2040 - Torres 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2042 - Mathiew 2004 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2043 - Andersen 2004 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2044 - Chadd 2001 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2045 - 2007 USP Dictionary of USAN and Int'l Drug Names | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2046 - 1997 INN Naming Guidelines | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2047 - McClean 2005 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2049 - HemeOnc Today | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2050 - Fatimah 2016 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2051 - Foote 1992 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2052 - Xiang 1995 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2053 - Soliris Current Label (06-2019 Label) | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2054 - Alexion Press Release 9-20-2006 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2055 - Alexion Press Release 9-26-2006 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2075 - GenScript Final Report | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2079 - Chang 2002 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2080 - Wang 1999 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2081 - Hermeling 2004 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2082 - Frokjaer | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2083 - Rosenberg 2006 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2084 - ICH Topic Q5C | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2085 - Q1AR2 Stability Testing Guidance | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2086 - Stebbings 2013 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2088 - Amgen Biosimilar Pipeline | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2089 - Generium Elizaria | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2090 - Samsung Bisolimilar Pipeline | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2091 - Harlowe and Lane 1988 | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2104 - 2024.02.23 Jeffrey Ravetch Deposition Transcript (FULL) | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2105 - Declaration of A. Casadevall (for POR) FINAL [504] | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2106 - 2024.02.20 Cindy Ippoliti Deposition Transcript (FULL) | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
2107 - Declaration of B. Trout (for POR) FINAL [504] | Mar 12, 2024 | EXHIBIT | PATENT OWNER |
EXPUNGED | Feb 12, 2024 | EXHIBIT | BOARD |
FIRST MODIFIED SCHEDULING ORDER | Feb 12, 2024 | PAPER | BOARD |
Ex 3004 | Feb 12, 2024 | EXHIBIT | BOARD |
Patent Owner's Notice of Deposition of Cindy Ippoliti, Pharm.D. | Feb 7, 2024 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Jeffrey V. Ravetch, M.D., Ph.D. | Feb 7, 2024 | PAPER | PATENT OWNER |
Institution Decision: Grant | Dec 8, 2023 | PAPER | BOARD |
US10703809 | Nov 15, 2023 | EXHIBIT | BOARD |
US10590189 | Nov 15, 2023 | EXHIBIT | BOARD |
Patent Owner's Sur-Reply to Petitioner's Reply to Preliminary Response | Oct 20, 2023 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Preliminary Response | Oct 5, 2023 | PAPER | PETITIONER |
Exhibit 3001 | Sep 22, 2023 | EXHIBIT | BOARD |
2005 - SOLIRIS Label | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2007 - Janeway and Travers | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2008 - McCloskey | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2009 - Torres | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2010 - Janda | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2011 - Pritsch 1996 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2012 - Pritsch 2000 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2013 - McLean | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2015 - Radbruch | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2016 - Bowdish 7,482,435 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2017 - Hawkins | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2018 - Alexion Pharmaceuticals Form 10K | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2019 - Ricklin and Lambris | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2020 - Alexion Press Release | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2021 - Alexion BusinessWire | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2022 - Arturo Casadevall MD PhD Declaration 504 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2024 - Bernhardt L. Trout PhD Declaration 504 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2026 - Michel Nussenzweig Declaration 504 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2097 - US Patent 6,355,245 B1 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2098 - Harlow and Lane Chapter 2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2100 - Rother 2007 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2101 - [1002] - Part 1 - Prosecution History for US Patent 9,718,880 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2101 - [1002] - Part 2 - Prosecution History for US Patent 9,718,880 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 1 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 2 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 3 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 4 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 5 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 6 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 7 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 8 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 9 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 10 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 11 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 12 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 13 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 14 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner Preliminary Response | Sep 12, 2023 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Jun 13, 2023 | PAPER | BOARD |
Notice : Power of Attorney | Jun 8, 2023 | PAPER | PATENT OWNER |
Notice : Mandatory Notice | Jun 8, 2023 | PAPER | PATENT OWNER |
Notice : Power of Attorney | May 31, 2023 | PAPER | PETITIONER |
U.S. Patent No. 9,725,504 B2 to Bell et al. | May 31, 2023 | EXHIBIT | PETITIONER |
Prosecution History for U.S. Patent No. 9,725,504 B2 | May 31, 2023 | EXHIBIT | PETITIONER |
U.S. Pat. Appl. Publ. No. 2003/0232972 A1 to Bowdish | May 31, 2023 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,355,245 B1 to Evans | May 31, 2023 | EXHIBIT | PETITIONER |
Mueller, et al., 34 Molecular Immunology 441 (1997) | May 31, 2023 | EXHIBIT | PETITIONER |
U.S. Patent Appl. Publ. No. 2005/0191298 A1 issued to Bell | May 31, 2023 | EXHIBIT | PETITIONER |
Tacken, et al., 106 Blood 1278 (2005) | May 31, 2023 | EXHIBIT | PETITIONER |
WO 97/11971 to Mueller et al. | May 31, 2023 | EXHIBIT | PETITIONER |
Thomas et al., 33 Molecular Immunology 1389 (1996) | May 31, 2023 | EXHIBIT | PETITIONER |
Hillmen, et al., 350 N. Engl. J. Med. 552 (2004) | May 31, 2023 | EXHIBIT | PETITIONER |
Hill, et al., 104 Blood 772a (2004) | May 31, 2023 | EXHIBIT | PETITIONER |
Hill, et al., 106 Blood 2559 (2005) | May 31, 2023 | EXHIBIT | PETITIONER |
Hillmen et al., 355 N. Engl. J. Med. 1233 (2006) | May 31, 2023 | EXHIBIT | PETITIONER |
Young et al., 108 Blood 290a (2006) | May 31, 2023 | EXHIBIT | PETITIONER |
Hillmen et al., 100 Blood 44a (2002) | May 31, 2023 | EXHIBIT | PETITIONER |
Hillmen et al., 102 Blood 509a (2003) | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpts from ...17 WHO Drug Information 115, WHO (2003) | May 31, 2023 | EXHIBIT | PETITIONER |
Guidelines on the Use of Int'l Nonproprietary Names (INNs) ... WHO (1997) | May 31, 2023 | EXHIBIT | PETITIONER |
Alexion Press Release, Alexion Issued Key C5 .... (March 15, 2002) | May 31, 2023 | EXHIBIT | PETITIONER |
WO 2005/007809 A2 issued to Rother et al. | May 31, 2023 | EXHIBIT | PETITIONER |
WO 2005/110481 A2 issued to Rother et al. | May 31, 2023 | EXHIBIT | PETITIONER |
Kaplan, Eculizumab Alexion, 3 Curr. Opin. Investig. Drugs 1017 (2002) | May 31, 2023 | EXHIBIT | PETITIONER |
Amgen v. Alexion, IPR2019-00739, Paper 15, Decision dated 8/30/2019) | May 31, 2023 | EXHIBIT | PETITIONER |
Amgen v. Alexion, IPR2019-00739, Paper 22, PO Response dated 11/22/2019 | May 31, 2023 | EXHIBIT | PETITIONER |
Amgen v. Alexion, IPR2019-00739, Paper 48, Termination dated June 1, 2020 | May 31, 2023 | EXHIBIT | PETITIONER |
Oppsn File History EP 1 720 571 B1 | May 31, 2023 | EXHIBIT | PETITIONER |
File History for EP 3 167 888 | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History 11/127,438 Amdmt in Resp OA dated 8/2/2011 | May 31, 2023 | EXHIBIT | PETITIONER |
Appl. for Extension of Patent Term - 6,355,245 dated May 11, 2007 | May 31, 2023 | EXHIBIT | PETITIONER |
Certificate Extending Patent Term, 6,355,245 dated June 11, 2010 | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History, 10,590,189 IDS dated May 31, 2019 | May 31, 2023 | EXHIBIT | PETITIONER |
Yoo et al., 170 J. Immunol. 3134 (2003) | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History 10,590,189 Non-Final Rejection dated 6/11/2019 | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History, 10,590,189 Notice of Allowance dated 1/22/2020 | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History, 10,590,189, Amdmt in Response dated 12/11/2019 | May 31, 2023 | EXHIBIT | PETITIONER |
Wypych et al., 283 J. Biol. Chem. 16194 (2008) | May 31, 2023 | EXHIBIT | PETITIONER |
Bournazos et al., 588 Nature 485 (2020) | May 31, 2023 | EXHIBIT | PETITIONER |
Bournazos et al., 124 J. Clinical Investigation 725 (2014) | May 31, 2023 | EXHIBIT | PETITIONER |
Baudino et al., 181 J. Immunology 4107 (2008) | May 31, 2023 | EXHIBIT | PETITIONER |
Takai et al., 76 Cell 519 (1994) | May 31, 2023 | EXHIBIT | PETITIONER |
Nimmerjahn et al., 8 Nat. Rev. Immunol. 34 (2008) | May 31, 2023 | EXHIBIT | PETITIONER |
Ravetch et al., 9 Annu. Rev. Immunol. 457 (1991) | May 31, 2023 | EXHIBIT | PETITIONER |
U.S. Pat. Appl. Publ. No. 2005/0271660 A1 issued to Wang | May 31, 2023 | EXHIBIT | PETITIONER |
Janeway, Chapters 1 & 3, Immunobiology etc., 1-34, 93-122 (5th ed 2001) | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpts Juo, Concise Dict. of Biomed & Molecular Biol (2d ed. 2001) | May 31, 2023 | EXHIBIT | PETITIONER |
Volkel, et al., 14 Protein Engineering 815 (2001) | May 31, 2023 | EXHIBIT | PETITIONER |
Lobo, et al., 93 Journal of Pharmaceutical Sciences 2645 (2004) | May 31, 2023 | EXHIBIT | PETITIONER |
Lipman, et al., 46 ILAR Journal 258 (2005) | May 31, 2023 | EXHIBIT | PETITIONER |
Lo, Chapter 7, ... Methods in Molecular Biology, Vol. 248, p 135-159 (2004) | May 31, 2023 | EXHIBIT | PETITIONER |
Reichmann et al., 332 Nature 323 (1988) | May 31, 2023 | EXHIBIT | PETITIONER |
Reichert, 4 mAbs 413 (2012) | May 31, 2023 | EXHIBIT | PETITIONER |
Alberts, et al., Molecular Biology of the Cell, pp. 551-98 (1994) | May 31, 2023 | EXHIBIT | PETITIONER |
Adderson et al., 89 J. Clin. Invest. 729 (1992) | May 31, 2023 | EXHIBIT | PETITIONER |
Genentech, Inc., Avastin 2004 Package Insert | May 31, 2023 | EXHIBIT | PETITIONER |
Millennium, Campath 2001 Package Insert | May 31, 2023 | EXHIBIT | PETITIONER |
ImClone Systems, Inc. Erbitux 2004 Package Insert | May 31, 2023 | EXHIBIT | PETITIONER |
Genentech, Inc. Herceptin 1998 Package Insert | May 31, 2023 | EXHIBIT | PETITIONER |
Centocor, Inc., Remicade 1998 Package Insert | May 31, 2023 | EXHIBIT | PETITIONER |
Genentech Inc. Rituxan 1997 Package Insert | May 31, 2023 | EXHIBIT | PETITIONER |
Daugherty et al., 58 Advanced Drug Delivery Reviews 686 (2006) | May 31, 2023 | EXHIBIT | PETITIONER |
Notice for Guidance on Excipients, Antioxidants etc., EP Agcy...Eval (2003) | May 31, 2023 | EXHIBIT | PETITIONER |
Excerpt from The Merck Manual (17th ed 1999) | May 31, 2023 | EXHIBIT | PETITIONER |
CDC Health, US, 2005 Chartbook and Trends in Health of Americans...... | May 31, 2023 | EXHIBIT | PETITIONER |
Petition : as filed | May 31, 2023 | PAPER | PETITIONER |
Declaration of Jeffrey V. Ravetch M.D. Ph.D. | May 31, 2023 | EXHIBIT | PETITIONER |
Declaration of Cindy Ippoliti, Pharm.D. | May 31, 2023 | EXHIBIT | PETITIONER |